Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term Ocular Effects of BHVI2 and Atropine in Myopic Children
NCT03690414Phase 1Completed
- Sponsor
- Hai Yen Eye Care
- Start
- Oct 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of 7-methylxanthine in myopia (3 arms), sponsored by Hai Yen Eye Care. Primary endpoints: Change in pupillary diameter at 1 month and Change in accommodative amplitude at 1 month. Started Oct 2018; status: completed.
02
Drugs
7-methylxanthine
03
Conditions
myopia
Beyond the preview
Go deeper on NCT03690414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03690414.